Objective: We sought to compare two approaches to antenatal testing for their impact on the workforce.
Introduction
Prior to 1978, over half of all women took a leave of absence from their job upon learning they were pregnant. 1 By the 1990s, 73% of women continued to work after a positive pregnancy test. 1 As obstetricians, we face the pressure of providing adequate prenatal care in an efficient manner to fit our patients' desires to remain productive, as only 27% chose to quit working during the course of pregnancy. 1 Surveillance of the fetus dates to 1818 when Mayor initiated the practice of auscultation. In 1968, a large, federally funded study demonstrated a poor correlation between auscultation findings and neonatal outcome. Owing to the inaccuracy of auscultation, focus shifted from fetal auscultation to the use of phonocardiography and external fetal monitoring. In 1969, the availability of the Hewlett-Packard external fetal monitoring/TM changed fetal monitoring and quickly became standard of care. 2 To date, no randomized controlled trials have demonstrated the effectiveness of antepartum fetal surveillance in reducing fetal mortality. However, observational studies have correlated the nonstress test (NST) with outcomes, leading to the NST as a method of antepartum fetal surveillance. [3] [4] [5] [6] [7] [8] [9] Another method commonly employed to assess the fetal state is the biophysical profile (BPP). The BPP combines the NST with four real-time sonographic observations: fetal movement, fetal tone, breathing motion by the fetus and amniotic fluid volume. The use of these observations to gauge fetal well-being is supported by various observational studies. 7,10 -16,21 -24 Although simple and inexpensive, the weekly NST has not been shown to reduce fetal mortality. 17 In fact, equivalent rates of antenatal fetal death are demonstrated when comparing the weekly NST with no testing at all. 17, 18 Because performing weekly NST has not shown any reduction in fetal mortality, NST has been utilized twice-weekly to increase likelihood of detecting fetal compromise. 19 By shortening the interval of testing, the twice-weekly NST decreases the number of false-negatives in terms of identifying impending stillbirth. Observational studies show that using the NST as a test twice a week reduces fetal mortality. 19 While both testsFweekly BPP and twice-weekly NSTFreduce fetal mortality, no study has ever shown either test to be superior in reducing fetal mortality rates. 3, 4, 19, 25 When reassuring scores are obtainedF'reactive NST' and '8/8 BPP,' both tests are reliable in predicting fetal well-being (that is, they have low false-negative rates of less than 0.5%). Likewise, the two tests correlate with one another on many levels. As per Vintzeleos et al. in 1983, BPPs of at least 8/8 are found in 95% of fetuses with reactive NSTs. All hypoxic fetuses had nonreactive NSTs and fetal breathing motion was absent. Presence of fetal heart rate accelerations and reactive NSTs were always associated with the presence of fetal movement and tone. However, when the NST is nonreactive and the BPP score is not reassuring, they both have high incidences of false-positives (approximately 50% for NST and high false-positive rates for each component of BPP). 26 Notably, the studies cited by The American College of Obstetricians and Gynecologists (ACOG) and by this paper in the use of fetal testing are all underpowered, limiting true comparison of the two testing formats. Nonetheless, both tests are often used interchangeably, as there are no data existing to show one test to be superior. At our institution, two acceptable testing protocols are used: the weekly BPPs and the twice-weekly NSTs. We employ these two tests and respective frequencies, because, in the limited data from underpowered studies available to base our practice, they have both been shown to be equivalent in reducing fetal mortality at the frequencies we use. 19, 20 Prior to this study, patient preference and the demands of choice of testing upon a patient have not been considered. Therefore, we sought to evaluate the choice of antenatal testing for its impact on a patient's social and work obligations. Additionally, we evaluated patient preferences regarding their method of antenatal testing.
Methods
After approval by the Christiana Hospital institutional review board and human experimentation committee, all patients referred to our antenatal testing unit were approached for participation. Patients were enrolled in one of the hospital's two accepted antenatal testing protocols: twice-weekly NSTs or BPPs. Method of testing was at the discretion of their physician. The primary outcome for this investigation was the time requirements of NST versus BPP on patients presenting for routine antenatal testing. Secondary outcomes related to how time from work was made up (for example, not made up, lost lunch, came to work early or stayed late, lost vacation time, lost sick time or other) and the impact of testing on maternal anxiety. A power calculation based on the assumption to detect a 15% difference in comparison of time commitment revealed that 90 patients in each group (NST and BPP) were required to achieve a P-value of 0.05 and b of 0.2. Similarly, a power calculation based on the assumption to detect a 15% difference in comparison of patient anxiety revealed that 90 patients in each group (NST and BPP) were required to achieve a P-value of 0.05 and b of 0.2.
After appropriate counseling, informed consent was obtained. Each patient who elected to participate was given a survey to complete. This survey included the following: maternal demographic characteristics, type of antenatal testing, time taken from work (defined as time spent away from scheduled shifts for their occupation, which was their stated form of employment), time to complete testing (defined as time of the appointment for test being performed), arrangement of child care, method of transportation, preferred frequency of testing if given a choice and whether they returned to work after testing as well as scores of pre-and post-anxiety. Anxiety was quantified by the following scale: 0 ¼ no anxiety, 1 ¼ little anxiety, 2 ¼ some anxiety, 3 ¼ anxiety, 4 ¼ high anxiety and 5 ¼ most ever anxiety. The completed forms were collected by research staff. Univariate analysis was performed using the Student's t-test, Mann-Whitney U-test, w 2 -test, Cochran-Mantel-Haenszel mean scores test or the Fisher exact test where appropriate. Patients who had NSTs were compared to those having BPPs.
Results
A total of 195 women were surveyed. Among them, 94 patients (48%) had NSTs and 101 patients (52%) had BPPs as their mode of testing. No intrauterine fetal demises were noted on follow-up in either group. Our data were assessed as exhibiting a normal distribution. Table 1 presents summary characteristics for the entire study cohort. Table 2 shows maternal demographic and employment characteristics by type of testing. There were no statistically significant differences in demographic characteristics, education or type of insurance. Although there were statistically significant differences between the two groups in terms of full-time (P ¼ 0.01) or part-time employment (P ¼ 0.01), there was no statistically significant difference in terms of those whose work was outside the home (P ¼ 0.52). There was also no significant difference in women working in a home business (P ¼ 0.68). Overall, 67% of patients worked and 17% of patients returned to work once their testing was complete. A total of 44% stated they were a full-time parent and 27% of patients had to arrange for child care to attend their testing. Table 3 shows the impact of testing on the workplace. Overall, women who had twice-weekly NST lost more time from work than those who had a BPP (218.4 versus 68.9 min; P<0.001). Notably, time listed is a mean time in minutes lost from work rather than time in minutes to actually perform the test. Mean values were used due to a normal distribution. To ascertain the impact of mode of testing on time lost from work, we evaluated the amount of time that would be gained if a patient who was evaluated by a twiceweekly NST was instead evaluated by weekly BPP. In our analysis, if the 96 women who received semiweekly testing had weekly testing, a total of 534.4 h would have been available for the workforce. In short, those enrolled in twice-weekly NSTs had both more time in minutes lost from work and more episodes of absences from work.
For patients who had to leave their job to attend testing, we asked how their time away from work was covered. Table 4 presents a summary of these results. While the majority of patients did not have to make up their time, a number of patients had to make arrangements to attend their testing, which included losing vacation time, lunch or sick time. We also asked patients if their testing had a negative impact on their lives. Nine patients (5%) reported that they lost wages to attend their testing, and four patients stated their testing compromised their work and threatened their job. Twelve patients (6%) stated that they had to skip a meal to have their testing.
One hundred and eighty one (90.5%) and eighty-seven (43.5%) patients found accuracy and reassurance, respectively, very important. Only 3% (n ¼ 6) and 4.5% (n ¼ 9) found cost of the test and cost of the test to the patient to be very important, while 37% (n ¼ 74) and 62% (n ¼ 124) found the same qualities not important. Similarly, more found duration of testing not to be important rather than very important (that is, n ¼ 49 versus n ¼ 14, respectively), as per Table 5 . When questioned about None of the above values varied by testing protocol. The only values recorded from the surveys and included in the analysis were qualities patients felt were 'very important' or 'not important.'
antenatal testing choice effects patient's work JM Denney et al pre-and post-test anxiety, patients reported lower anxiety levels after testing (P<0.0001), as reported in Table 6 . Finally, we asked patients if they could choose their method of testing or frequency of testing, what method would they prefer. Overall, 120 patients (61%) stated they would prefer weekly testing over twice-weekly evaluations. For patients who were having twice-weekly testing, 80% reported they would prefer only weekly testing.
Discussion
The results of this study demonstrate that many obstetrical patients receiving antenatal testing experience consequences outside of the pregnancy due to required testing. We demonstrate the need to arrange transportation and child care, loss of time at work, wages, vacation time, sick time, lunch breaks and additional hours required either before or after work to meet the obligations of their antenatal appointments. While both forms of testing placed demands upon our patients, in our evaluation, weekly BPP was far less taxing on a patient's time commitment. This study also demonstrates that patients who had twice-weekly NSTs would have preferred weekly BPPs. Our patients face the pressure of balancing work as well as taking steps to reassure themselves and their physicians that their unborn child is not compromised and in need of delivery. When the NST is done twice a week, a reduction of fetal mortality is accomplished at a rate similar to that when weekly BPP is used (that is, there is no statistically significant difference in fetal mortality from weekly BPP when NST is done twice-weekly). Given that 83% of the patients having twice-weekly NST had preferred an equivalent weekly test, consideration should be given to patient desires when we send expectant mothers to testing. Using weekly BPP would require less time taken from the workforce. From the patient's perspective, the most important testing qualities are accuracy and reassurance, while time and cost are not important. Patient anxiety levels decreased following antenatal testing.
Two hundred and eighteen minutes in the twice-weekly NST group versus 103 min in the weekly BPP group in regard to total missed time per week shows that use of twice-weekly NST results in more than doubling the amount of time spent away from work. Of those enduring the twice-weekly testing, 83% reported a preference toward an equivalent weekly test. As evidenced by this study, scheduling different testing protocols have differing effects and demands on the lives of patients involved. In our group, compliance was not an issue. However, if patients were to possess knowledge that two testing protocols are equivalent in terms of identifying a distressed fetus but differ drastically in time commitments, it appears clear that they would choose the testing protocol that required the least amount of time commitment on their end.
The generalizability of this study is limited because many testing centers perform the 'modified BPP'Fconsisting of an NST with the amniotic fluid index. The modified BPP is utilized for several advantages, including time, accuracy and the ability to approximate the BPPs. If the modified BPP is abnormal, a backup test is performed, typically the remainder of the BPP. Additionally, the study is limited by the lack of adequately powered, randomized controlled trials comparing NSTs versus BPPs. The American College of Obstetricians and Gynecologists does not take a position on the frequency of either test NST or BPP. Furthermore, in the most recent practice bulletin, the American College of Obstetricians and Gynecologists provides no guidelines regarding frequency of antenatal testing, and offers no comments regarding existing literature on antenatal testing protocols and effects on fetal mortality. The American College of Obstetricians and Gynecologists states that either testFNST or BPPFis an acceptable test to implement. Owing to the lack of adequately powered trials, we would like to call for a large, multicenter, prospective study that could be done by the Maternal Fetal Medicine Units, for example, to address optimal antenatal testing.
Currently, the individual practitioner is left to decide what conditions to institute fetal testing protocols, when to start testing as well as the frequency of testing. 3 Testing protocols may vary widely among individual practitioners, institutions and different regions of the country, depending on training, medical-legal environments and individual/institutional perspectives on existing literature, as many studies contradict one another. 4 In light of the effects and stress on our patients, we might consider utilizing the weekly BPPs rather than twice-weekly NSTs when medical and/or obstetrical issues indicate a need for fetal surveillance, until further clinical evidence demonstrates a difference between these two protocols. 
